We’re focused on developing clinical management tools and therapies to improve outcomes for some
of the most damaging and prevalent congenital diseases affecting patients at the start of life.
Gravid integrates the latest technologies with medical interventions to unlock their potential
in the fight against diseases that we can and will conquer.
Please visit us again soon to learn about the initial set of diseases we have targeted.
Dan has spent over 16 years in corporate development roles at diagnostic, therapeutic and biotechnology tool companies and is a lifelong student of biology, medicine and finance. He has a broad range of business development experience evaluating business opportunities and crafting and implementing strategies to successfully build them from the ground up. He holds a BS and MS from UCSD and an MBA from London Business School.
Mike has over 20 years’ experience in founding and growing Diagnostics, Devices and CRO companies, developing greater than 20 clinical products that have improved the lives of patients and physicians. He holds a BA from U of Chicago, an MD from Yale, and completed clinical and scientific training at U Penn. and the NIH.